ர்ப் நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ர்ப் நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ர்ப் நிதி Today - Breaking & Trending Today

Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results


Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results
News provided by
Share this article
Share this article
NEWARK, N.J., March 17, 2021 /PRNewswire/  Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.0 million and a loss per share of $0.50 for the second quarter of its 2021 fiscal year, the three months ended January 31, 2021.
Q2 FY 2021 Consolidated Financial and Operational Highlights
Revenue of $1.0 million, generated by Rafael Holdings real estate portfolio, decreased from $1.2 million in the year-ago quarter due, in part, to the sale of its building in Piscataway, NJ.
Loss per share of $0.50 compared to a loss per share of $0.08 in the year ago quarter primarily due to a $7.0 million impairment of the company s interest in Altira, as described below. ....

United States , Howard Jonas , Fordoz Pharma , Joshua Rabinowitz , Third Party , Sarcoma Alliance For Research , Lipomedix Pharmaceuticals Ltd , Rafael Pharmaceuticals , Princeton University Office Of Technology Licensing , Rafael Holdings Inc , Barer Institute , Rafael Pharmaceuticals Inc , Investment In Rafael Pharmaceuticals , Rp Finance , Rafael Holdings , Drug Administration , Rafael Holding , Department Of Chemistry , Company Class , Other Pharmaceuticals , Rafael Holding Board Of Directors , Holding Board , Ameet Mallik , Chief Executive Office , Rafael Holding Chief Commercial , Rafael Pharmaceutical ,

Rafael Holdings Reports First Quarter Fiscal Year 2021 Results


Rafael Holdings Reports First Quarter Fiscal Year 2021 Results
News provided by
Share this article
Share this article
NEWARK, N.J., Dec. 15, 2020 /PRNewswire/  Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.1 million and a loss per share of $0.09 for the first quarter of its 2021 fiscal year, the three months ended October 31, 2020.
Q1 FY 2021 Consolidated Financial Highlights
Revenue of $1.1 million in Q1 FY 2021, generated by Rafael Holdings real estate portfolio, decreased from $1.2 million in the year-ago quarter.
Loss per share of $0.09, a decrease from $0.10 in the year ago quarter largely due to a gains on the sale of the Company s commercial real estate property in Piscataway, New Jersey and other investments which more than offset the increased research and development expense. ....

Rp Finance , Rafael Pharmaceuticals , Rafael Holdings Inc , Other Pharmaceuticals , Rafael Holdings , ர்ப் நிதி , ரஃபேல் மருந்துகள் , ரஃபேல் ஹோல்டிங்ஸ் இன்க் , அதர் மருந்துகள் , ரஃபேல் ஹோல்டிங்ஸ் ,